(Q45027885)

English

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

Paulus Kirchhof

26

1 reference

Europe PubMed Central

8 December 2017

Antoine Leenhardt

object named as

Antoine Leenhardt

13

0 references

Heart Rhythm Society

35

object named as

Heart Rhythm Society

1 reference

Europe PubMed Central

8 December 2017

European Heart Rhythm Association

36

object named as

European Heart Rhythm Association

1 reference

Europe PubMed Central

8 December 2017

Susan Etheridge

31

object named as

Susan P Etheridge

1 reference

Europe PubMed Central

8 December 2017

Jonathan M Kalman

24

object named as

Jonathan Kalman

1 reference

Europe PubMed Central

8 December 2017

8

object named as

Josep Brugada

1 reference

Europe PubMed Central

8 December 2017

author name string

Silvia G Priori

1

1 reference

Europe PubMed Central

8 December 2017

Arthur A Wilde

2

1 reference

Europe PubMed Central

8 December 2017

Minoru Horie

3

1 reference

Europe PubMed Central

8 December 2017

Yongkeun Cho

4

1 reference

Europe PubMed Central

8 December 2017

Elijah R Behr

5

1 reference

Europe PubMed Central

8 December 2017

Charles Berul

6

1 reference

Europe PubMed Central

8 December 2017

Nico Blom

7

1 reference

Europe PubMed Central

8 December 2017

Chern-En Chiang

9

1 reference

Europe PubMed Central

8 December 2017

Heikki Huikuri

10

1 reference

Europe PubMed Central

8 December 2017

Prince Kannankeril

11

1 reference

Europe PubMed Central

8 December 2017

Andrew Krahn

12

1 reference

Europe PubMed Central

8 December 2017

Arthur Moss

14

1 reference

Europe PubMed Central

8 December 2017

Peter J Schwartz

15

1 reference

Europe PubMed Central

8 December 2017

Wataru Shimizu

16

1 reference

Europe PubMed Central

8 December 2017

Gordon Tomaselli

17

1 reference

Europe PubMed Central

8 December 2017

Cynthia Tracy

18

1 reference

Europe PubMed Central

8 December 2017

Document Reviewers

19

1 reference

Europe PubMed Central

8 December 2017

Michael Ackerman

20

1 reference

Europe PubMed Central

8 December 2017

Bernard Belhassen

21

1 reference

Europe PubMed Central

8 December 2017

N A Mark Estes

22

1 reference

Europe PubMed Central

8 December 2017

Diane Fatkin

23

1 reference

Europe PubMed Central

8 December 2017

Elizabeth Kaufman

25

1 reference

Europe PubMed Central

8 December 2017

Eric Schulze-Bahr

27

1 reference

Europe PubMed Central

8 December 2017

Christian Wolpert

28

1 reference

Europe PubMed Central

8 December 2017

Jitendra Vohra

29

1 reference

Europe PubMed Central

8 December 2017

Marwan Refaat

30

1 reference

Europe PubMed Central

8 December 2017

Robert M Campbell

32

1 reference

Europe PubMed Central

8 December 2017

Edward T Martin

33

1 reference

Europe PubMed Central

8 December 2017

Swee Chye Quek

34

1 reference

Europe PubMed Central

8 December 2017

Asia Pacific Heart Rhythm Society

37

1 reference

Europe PubMed Central

8 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 August 2013

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

15

1 reference

Europe PubMed Central

8 December 2017

10

1 reference

Europe PubMed Central

8 December 2017

1389-1406

1 reference

Europe PubMed Central

8 December 2017

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Guidelines for the diagnosis and management of syncope (version 2009)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research I

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Prevalence of the congenital long-QT syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

QTc behavior during exercise and genetic testing for the long-QT syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Diagnostic criteria for the long QT syndrome. An update

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk stratification in the long-QT syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

All LQT3 patients need an ICD: true or false?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk of fatal arrhythmic events in long QT syndrome patients after syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Implantable cardioverter defibrillator in high-risk long QT syndrome patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Brugada syndrome: report of the second consensus conference.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Brugada Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Natural history of Brugada syndrome: insights for risk stratification and management

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Gender differences in clinical manifestations of Brugada syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Radiofrequency ablation of ventricular fibrillation and multiple right and left atrial tachycardia in a patient with Brugada syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading [...]

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Inherited calcium channelopathies in the pathophysiology of arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The role of thoracic epidural blockade in predicting responsiveness to left sympathetic denervation in patients with catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Short QT Syndrome: a familial cause of sudden death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Low birth weight and increased sympathetic activity

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mutation in the KCNQ1 gene leading to the short QT-interval syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Long-term follow-up of patients with short QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Short QT syndrome: pharmacological treatment

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden cardiac arrest associated with early repolarization

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Long-term outcome associated with early repolarization on electrocardiography

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Inferolateral early repolarization in athletes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The early repolarization pattern in the general population: clinical correlates and heritability

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Early repolarization in an ambulatory clinical population

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Early repolarization pattern and risk for arrhythmia death: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Augmentation of J waves and electrical storms in patients with early repolarization

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Mechanisms of inherited cardiac conduction disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Inherited conduction system abnormalities--one group of diseases, many genes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden, unexpected cardiac or unexplained death in England: a national survey.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden unexplained death in childhood (1-4 years) in Ireland: an epidemiological profile and comparison with SIDS.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk factor changes for sudden infant death syndrome after initiation of Back-to-Sleep campaign

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Guidelines for autopsy investigation of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Genetics and cardiovascular disease--causes and prevention of unexpected sudden adult death: the role of the SADS clinic.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Family and population strategies for screening and counselling of inherited cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Guidelines for genetic testing of inherited cardiac disorders

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Prevalence and Characteristics of Early Repolarization in the CASPER Registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT272

21 January 2018

Identifiers

10.1093/EUROPACE/EUT272

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45027885&oldid=2063411153"